Nirogi, R., Ieni, J., Goyal, V. K., Ravula, J., Jetta, S., Shinde, A., . . . Cummings, J. (2022). Effect of masupirdine (SUVN‐502) on cognition in patients with moderate Alzheimer's disease: A randomized, double‐blind, phase 2, proof‐of‐concept study. Wiley.
Chicago Style (17th ed.) CitationNirogi, Ramakrishna, et al. Effect of Masupirdine (SUVN‐502) on Cognition in Patients with Moderate Alzheimer's Disease: A Randomized, Double‐blind, Phase 2, Proof‐of‐concept Study. Wiley, 2022.
MLA (9th ed.) CitationNirogi, Ramakrishna, et al. Effect of Masupirdine (SUVN‐502) on Cognition in Patients with Moderate Alzheimer's Disease: A Randomized, Double‐blind, Phase 2, Proof‐of‐concept Study. Wiley, 2022.
Warning: These citations may not always be 100% accurate.